Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle Holen

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative studyAlejandro D Ricart, Anthony W Tolcher, Glenn Liu, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2008
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumorsWilliam Schelman, Sherry Morgan-Meadows, Howard Bailey, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2008
Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumorsJill Kolesar, Wei Huang, Jens Eickhoff, et al.
Investigational New Drugs|March 23, 2011
A phase I trial of MK-0731, a kinesin spindle protein (KSP) inhibitor, in patients with solid tumorsKyle Holen, Robert DiPaola, Glenn Liu, et al.
Investigational New Drugs|June 12, 2014
A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumorsJames M Cleary, Caio Max S Rocha Lima, Herbert I Hurwitz, et al.
Investigational New Drugs|April 21, 2015
A phase 1 study of ABT-806 in subjects with advanced solid tumorsJames M Cleary, David A Reardon, Nilofer Azad, et al.
Investigational New Drugs|September 15, 2010
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinomaGeorge P Kim, Michelle R Mahoney, Daniel Szydlo, et al.
Journal of Neuro-Oncology|February 16, 2015
Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 studyMinesh P Mehta, Ding Wang, Fen Wang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative studyAlejandro D Ricart, Anthony W Tolcher, Glenn Liu, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2008
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumorsWilliam Schelman, Sherry Morgan-Meadows, Howard Bailey, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2008
Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumorsJill Kolesar, Wei Huang, Jens Eickhoff, et al.
Investigational New Drugs|March 23, 2011
A phase I trial of MK-0731, a kinesin spindle protein (KSP) inhibitor, in patients with solid tumorsKyle Holen, Robert DiPaola, Glenn Liu, et al.
Investigational New Drugs|June 12, 2014
A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumorsJames M Cleary, Caio Max S Rocha Lima, Herbert I Hurwitz, et al.
Investigational New Drugs|April 21, 2015
A phase 1 study of ABT-806 in subjects with advanced solid tumorsJames M Cleary, David A Reardon, Nilofer Azad, et al.
Investigational New Drugs|September 15, 2010
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinomaGeorge P Kim, Michelle R Mahoney, Daniel Szydlo, et al.
Journal of Neuro-Oncology|February 16, 2015
Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 studyMinesh P Mehta, Ding Wang, Fen Wang, et al.
Pageof 2